TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
29 hedge funds and large institutions have $1.39M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$194K | |
| 2 | +$86.9K | |
| 3 | +$78.4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$39.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$33.5K |
Top Sellers
| 1 | -$484K | |
| 2 | -$50.2K | |
| 3 | -$45.3K | |
| 4 |
Squarepoint
New York
|
-$10K |
| 5 |
GS
GTS Securities
New York
|
-$2.76K |